These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 9198842
1. [New wave of chemotherapeutic agents: update in pulmonary oncology]. Sculier JP. Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842 [No Abstract] [Full Text] [Related]
2. New chemotherapeutic agents for non-small cell lung cancer. Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG. Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411 [Abstract] [Full Text] [Related]
3. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N. Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985 [Abstract] [Full Text] [Related]
4. Promising new agents in the treatment of non-small cell lung cancer. Edelman MJ, Gandara DR. Cancer Chemother Pharmacol; 1996 Jan; 37(5):385-93. PubMed ID: 8599859 [Abstract] [Full Text] [Related]
7. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference? Ferrigno D, Buccheri G. Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840 [Abstract] [Full Text] [Related]
8. [New promising anticancer drugs for lung cancer]. Ariyoshi Y, Sugiura T. Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416 [Abstract] [Full Text] [Related]
9. [New cytostatics in the therapy of non-small cell bronchial carcinoma]. Serke M, Schönfeld N, Loddenkemper R. Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648 [No Abstract] [Full Text] [Related]
10. New drugs in non-small cell lung cancer. An overview. Giaccone G. Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924 [Abstract] [Full Text] [Related]
12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. Health Technol Assess; 2001 Dec; 5(32):1-195. PubMed ID: 12065068 [Abstract] [Full Text] [Related]
13. [New drugs in gastrointestinal oncology. Current status and future directions]. Conroy T, Paillot B, Adenis A. Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534 [No Abstract] [Full Text] [Related]
14. New agents in the treatment of small cell lung cancer. Ghaemmaghami M, Jett JR. Chest; 1998 Jan; 113(1 Suppl):86S-91S. PubMed ID: 9438696 [Abstract] [Full Text] [Related]
16. New drugs for treating small cell lung cancer. Ettinger DS. Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957 [Abstract] [Full Text] [Related]
17. [Lung cancer]. Furuse K. Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236 [Abstract] [Full Text] [Related]
18. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment. Meert AP, Berghmans T, Branle F, Lemaître F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP. Anticancer Res; 1999 Oct; 19(5C):4379-90. PubMed ID: 10650780 [Abstract] [Full Text] [Related]
19. [Maintenance chemotherapy in advanced NSCLC]. Krazkowski M. Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150 [No Abstract] [Full Text] [Related]
20. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L, Giani L, Vaghi M, Ardizzoia A, Gardani GS. Int J Biol Markers; 2004 Feb; 19(2):135-40. PubMed ID: 15255546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]